Literature DB >> 11275652

New insights into the pathogenesis of pulmonary inflammation in preterm infants.

C P Speer1.   

Abstract

Chronic lung disease (CLD) and bronchopulmonary dysplasia are associated with a significant inflammatory response of the airways and the interstitium of the lungs. Besides inflammatory cells, various cytokines, lipid mediators, proteolytic enzymes and toxic oxygen radicals may play an essential role in the pathogenesis of this disease. Intrauterine exposure to chorioamnionitis or proinflammatory cytokines has been shown to induce a pulmonary and systemic inflammatory response in the fetus. In this subgroup, antenatal infection may prime the lung such that minimally injurious postnatal events provoke an excessive inflammatory response in the airways and the pulmonary tissue. Inflammation and lung injury most certainly affect normal alveolization and pulmonary vascular development in preterm infants with CLD. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11275652     DOI: 10.1159/000047092

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  33 in total

Review 1.  Frontiers in pulmonary hypertension in infants and children with bronchopulmonary dysplasia.

Authors:  Joseph M Collaco; Lewis H Romer; Bridget D Stuart; John D Coulson; Allen D Everett; Edward E Lawson; Joel I Brenner; Anna T Brown; Melanie K Nies; Priya Sekar; Lawrence M Nogee; Sharon A McGrath-Morrow
Journal:  Pediatr Pulmonol       Date:  2012-07-06

2.  The diagnostic performance of the Mass Restricted (MR) score in the identification of microbial invasion of the amniotic cavity or intra-amniotic inflammation is not superior to amniotic fluid interleukin-6.

Authors:  Roberto Romero; Nicholas Kadar; Jezid Miranda; Steven J Korzeniewski; Alyse G Schwartz; Piya Chaemsaithong; Wade Rogers; Eleazar Soto; Francesca Gotsch; Lami Yeo; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2013-12-16

3.  Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants.

Authors: 
Journal:  Paediatr Child Health       Date:  2002-01       Impact factor: 2.253

4.  Association of BPD and IVH with early neutrophil and white counts in VLBW neonates with gestational age <32 weeks.

Authors:  M Palta; M Sadek-Badawi; D P Carlton
Journal:  J Perinatol       Date:  2008-06-19       Impact factor: 2.521

5.  Neutrophil and monocyte toll-like receptor 4, CD11b and reactive oxygen intermediates, and neuroimaging outcomes in preterm infants.

Authors:  Fiona M O'Hare; William Watson; Amanda O'Neill; Tim Grant; Chike Onwuneme; Veronica Donoghue; Eoghan Mooney; Paul Downey; John Murphy; Anne Twomey; Eleanor J Molloy
Journal:  Pediatr Res       Date:  2015-03-31       Impact factor: 3.756

6.  A novel molecular microbiologic technique for the rapid diagnosis of microbial invasion of the amniotic cavity and intra-amniotic infection in preterm labor with intact membranes.

Authors:  Roberto Romero; Jezid Miranda; Tinnakorn Chaiworapongsa; Piya Chaemsaithong; Francesca Gotsch; Zhong Dong; Ahmed I Ahmed; Bo Hyun Yoon; Sonia S Hassan; Chong Jai Kim; Steven J Korzeniewski; Lami Yeo
Journal:  Am J Reprod Immunol       Date:  2014-01-13       Impact factor: 3.886

7.  NF-kappaB in tracheal lavage fluid from intubated premature infants: association with inflammation, oxygen, and outcome.

Authors:  A Bourbia; M A Cruz; H J Rozycki
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-07-27       Impact factor: 5.747

Review 8.  Current perspectives on the prevention and management of chronic lung disease in preterm infants.

Authors:  Prakesh S Shah
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 9.  The potential role for arachidonic and docosahexaenoic acids in protection against some central nervous system injuries in preterm infants.

Authors:  M A Crawford; I Golfetto; K Ghebremeskel; Y Min; T Moodley; L Poston; A Phylactos; S Cunnane; W Schmidt
Journal:  Lipids       Date:  2003-04       Impact factor: 1.880

10.  Soluble ST2 in the fetal inflammatory response syndrome: in vivo evidence of activation of the anti-inflammatory limb of the immune response.

Authors:  Tamara Stampalija; Roberto Romero; Steven J Korzeniewski; Piya Chaemsaithong; Jezid Miranda; Lami Yeo; Zhong Dong; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2013-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.